ABAleksander I. Berishvili

Aleksander I. Berishvili

*This is an algorithmically generated author record based on publicly available information.

Aleksander I. Berishvili has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • T. M. Kochoyan

    N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

    3 shared publications
  • Anna Genrikhovna Kedrova

    Federal Research and Clinical Center for Specialized Medical Care and Medical Technologies, Federal Biomedical Agency of the Russian Federation

    2 shared publications
  • Array М. Кочоян

    Научно-исследовательский институт клинической онкологии ФГБУ «РОНЦ им. Н.Н. Блохина» Минздрава России

    2 shared publications
  • R. A. Kerimov

    N. N. Blokhin Russian Cancer Research Center at the Ministry of Health of Russia

    2 shared publications
  • S. B. Polikarpova

    I. M. Sechenov First Moscow State Medical University at the Ministry of Health of Russia

    2 shared publications
  • A. A. Pukhov

    LLC “Akvion

    1 shared publication

Latest Publications

  • Open Access

    Mastalgia: current trends and recommendations

    by A. I. Berishvili, T. A. Greyan, O. V. Zaytseva, A. A. Pukhov

    Mastalgia is the most common manifestation of mastopathy. Up to 70 % of women experiencing breast pain report a significant decrease in their quality of life; however, hormone therapy is not indicated and suitable for everyone. The main aim of a clinician in this case is to exclude cancer and choose appropriate treatment to manage pain. First-line therapy for such patients may not necessarily include medications.The aim of this work was to identify the most effective non-pharmacological treatments for patients with mastalgia. We conducted a search of publications assessing various methods of mastalgia management in both Russian and foreign databases (PubMed, CyberLeninka, Elibrary, Google Scholar). We used the following key words: “mastalgia”, “cyclic mastalgia“, and “non-cyclic mastalgia“.Visual demonstration of the fact the woman has no risk of breast cancer (after examination) and proper explanation can reduce complaints of mastalgia without any additional treatment. Recommendation to change a bra also brings a significant relief to the majority of women. Reduced consumption of methylxanthines and fats along with sufficient intake of fiber and liquid can be beneficial for patients. Dietary modifications with certain nutrients (such as indole-3-carbinol and trans-resveratrol) might significantly improve the quality of life of patients with mastalgia. Relaxation practices can also mitigate mastalgia.Most patients with mastalgia can be managed without any medications if they are reassured about the absence of cancer risk, choose a well-fitting and supportive bra, have psychoemotional support, and modify their diet.


  • Open Access

    A clinical case of successful treatment of a giant serous endometrial carcinoma imitating ovarian cancer

    by Aleksander I. Berishvili, Yuri V. Ivanov, Dmitry P. Lebedev, Fedor G. Zabozlaev, Edward V. Kravchenko, Tatiana V. Klypa, Anna G. Kedrova

    Background: Giant tumors of the abdominal cavity, as a rule, occur in elderly patients with characteristic features and represent a serious problem in terms of choosing a radical method of therapy. Of particular difficulty are cases of giant serous endometrial cancer, requiring a differential diagnosis with ovarian cancer. Clinical case description: A clinical case of giant serous endometrial cancer mimicking ovarian cancer in a 55-year-old woman is presented. The patient came to the oncology department with complaints of abdominal enlargement, difficulty breathing and bloody discharge from the genital tract. The examination revealed the following: a giant formation (4065 cm), occupying the entire pelvic and the entire abdominal cavities, ascites, lesions of the retroperitoneal lymph nodes, and the greater omentum, an umbilical hernia. A chest CT showed multiple contrast-accumulating circular shadows of 313 mm (metastases). By the decision of the council, after the preliminary chemoembolization of both the uterine and ovarian arteries, a supravaginal amputation of the uterus with appendages was performed, along with the resection of the greater omentum, removal of the umbilical hernia with positioning a plastic mesh implant and excision of an excess skin flap. The histological examination of the intraoperative material made it possible to verify the diagnosis of a serous endometrial carcinoma with subtotal tumor necrosis, the myometrium invasion of more than a half of its thickness, with the egress to the perimetrium, metastatic lesions of both ovaries, the greater omentum, anterior abdominal wall. Stage T3b (FIGO IIIB). In the postoperative period, 6 courses of Paclitaxel / Carboplatin (AUC4-5) chemotherapy were carried out with a pronounced clinical effect. The patient was discharged in a satisfactory condition. The control PET-CT scan after the 6th chemotherapy course showed no pathology in the thoracic cavity, and no process progress in the abdominal cavity. Currently, the remission of the disease is 9 months. Conclusion: An algorithm for the diagnostic measures aimed at making the correct diagnosis is presented, and the tactics of treating a patient with giant serous endometrial cancer is described.

  • Open Access

    CO2 laser in the diagnostics of resection margins in breast tumors

    by A. I. Berishvili, T. M. Kochoyan, A. K. Dmitriev, A. N. Konovalov, V. A. Ulyanov, А. G. Kedrova

    To diagnostics of the evaporation of tumor tissue by radiation of single-mode medical CO2 laser is proposed a laser Doppler diagnostic method based on autodyne detection (reception on a laser resonator) of backscattered radiation from the evaporation zone. Intraoperative diagnostics of laser tissue evaporation lets surgeon to determine in real time tumour margins and evaporate it without additional normal tissue traumatization. The sensitivity limits of the method were studied on samples of malignant and benign tumors of breast together with plots of healthy tissue in vitro. It was shown that areas of tumor tissue are well determined by the autodyne method in 80 % of cases.

  • Open Access

    SENTINEL LYMPH NODES IN ENDOMETRIAL CANCER

    by Array И. Беришвили, O. V. Li, T. M. Kochoyan, N. V. Levkina, R. A. Kerimov, S. B. Polikarpova, Array М. Кочоян

    Endometrial cancer (EC) typically is treated surgically. Because of the adjuvant treatment implications, complete surgical staging including lymphadenectomy is recommended for high-risk ECs. Sentinel lymph node mapping has the potential to provide information about lymph node metastasis while avoiding potential complications of extended lymph node dissection.


  • Open Access

    METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS

    by S. N. Tadzhibov, S. B. Polikarpova, T. M. Kochoyan, N. I. Mehtieva, R. A. Kerimov, Array И. Беришвили, Array М. Кочоян

    Introduction. In 70 % of patients with metastases of breast cancer in the ovaries, ovarian damage is detected simultaneously with the primary tumor, which affects the choice of tactics for diagnosis and treatment of such patients.Materials and methods. The data of 30 patients with breast cancer with ovarian metastases and 35 patients with breast cancer without metastatic ovarian damage, which comprised the main and control groups. The groups were comparable in terms of main demographic and clinical features. Results. In the study of distant indicators, it is proved that the presence of metastases in the ovaries is a reliable adverse factor predicting a 3-year overall survival of patients older than 50 years who are in menopause and who received combined treatment.Conclusions. Surgical treatment significantly increases the 3and 5-year overall survival of breast cancer patients with ovarian metastases (83.3 %), while the combined treatment of such patients does not significantly affect overall survival despite the high sensitivity of breast cancer to chemotherapy. This may be due to the fact that the patients included in the study who received the combined treatment had metastases to other organs (liver, lungs, bones).